Latest Molecular genetics Stories
New Preclinical Results in Non-Human Primates Demonstrate Significant and Sustained Reduction of Transthyretin Using its Proprietary LUNARTM Delivery Technology SAN DIEGO, Jan.
SEATTLE, Jan. 10, 2014 /PRNewswire/ -- PhaseRx, Inc., an RNA therapeutics company, today announced the appointment of Michael Houston, Ph.D., as its Vice President, Therapeutics Development.
National Institute of Mental Health Director Salutes UVA Discovery Charlottesville, VA (PRWEB) January 08, 2014 For the second year in a row, groundbreaking
CAMBRIDGE, Mass., Jan.
CSO to Present Data on the Recently Launched SURE CHO-Mplus™ Libraries Geneva, Switzerland (PRWEB) December 17, 2013 Selexis SA, a serial innovation
Genetic researchers have devised a new technique that lets them permanently and selectively delete genes from a cell's DNA.
Researchers at the University of California, San Diego School of Medicine have successfully targeted T lymphocytes – which play a central role in the body's immune response – with another type of white blood cell engineered to synthesize and deliver bits of non-coding RNA or microRNA (miRNA).
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.